WO2005045062A3 - Gene expression and polymorphisms associated with lung cancer - Google Patents

Gene expression and polymorphisms associated with lung cancer Download PDF

Info

Publication number
WO2005045062A3
WO2005045062A3 PCT/US2004/035690 US2004035690W WO2005045062A3 WO 2005045062 A3 WO2005045062 A3 WO 2005045062A3 US 2004035690 W US2004035690 W US 2004035690W WO 2005045062 A3 WO2005045062 A3 WO 2005045062A3
Authority
WO
WIPO (PCT)
Prior art keywords
gene expression
lung cancer
polymorphisms associated
gene
las1
Prior art date
Application number
PCT/US2004/035690
Other languages
French (fr)
Other versions
WO2005045062A2 (en
Inventor
Ming You
Zhongqiu Zhang
Manabu Futamura
Original Assignee
Univ Ohio State Res Found
Ming You
Zhongqiu Zhang
Manabu Futamura
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Ohio State Res Found, Ming You, Zhongqiu Zhang, Manabu Futamura filed Critical Univ Ohio State Res Found
Priority to CA002543965A priority Critical patent/CA2543965A1/en
Priority to EP20040796566 priority patent/EP1753882A2/en
Priority to AU2004288177A priority patent/AU2004288177A1/en
Publication of WO2005045062A2 publication Critical patent/WO2005045062A2/en
Publication of WO2005045062A3 publication Critical patent/WO2005045062A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Methods are provided relating to the identification and treatment of cancers that involve altered expression of the Lung Adenoma Susceptibility-1 Gene (Las1) gene and/or its product, the Las1 protein.
PCT/US2004/035690 2003-10-27 2004-10-27 Gene expression and polymorphisms associated with lung cancer WO2005045062A2 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
CA002543965A CA2543965A1 (en) 2003-10-27 2004-10-27 Gene expression and polymorphisms associated with lung cancer
EP20040796566 EP1753882A2 (en) 2003-10-27 2004-10-27 Gene expression and polymorphisms associated with lung cancer
AU2004288177A AU2004288177A1 (en) 2003-10-27 2004-10-27 Gene expression and polymorphisms associated with lung cancer

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US51467303P 2003-10-27 2003-10-27
US60/514,673 2003-10-27

Publications (2)

Publication Number Publication Date
WO2005045062A2 WO2005045062A2 (en) 2005-05-19
WO2005045062A3 true WO2005045062A3 (en) 2005-07-28

Family

ID=34572767

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2004/035690 WO2005045062A2 (en) 2003-10-27 2004-10-27 Gene expression and polymorphisms associated with lung cancer

Country Status (4)

Country Link
EP (1) EP1753882A2 (en)
AU (1) AU2004288177A1 (en)
CA (1) CA2543965A1 (en)
WO (1) WO2005045062A2 (en)

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
DOSEFF ET AL.: "LAS1 is an essential nuclear protein involved in cell morphogenesis and cell surface growth", GENETICS, vol. 141, November 1995 (1995-11-01), pages 857 - 871, XP002987299 *

Also Published As

Publication number Publication date
EP1753882A2 (en) 2007-02-21
WO2005045062A2 (en) 2005-05-19
AU2004288177A1 (en) 2005-05-19
CA2543965A1 (en) 2005-05-19

Similar Documents

Publication Publication Date Title
WO2003004989A3 (en) Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer
WO2002071928A3 (en) Nucleic acid molecules and proteins for the identification, assessment, prevention, and therapy of ovarian cancer
EP2433956A3 (en) Identification of tumor-associated antigens for diagnosis and therapy
WO2007076423A3 (en) INHIBITORS OF Akt ACTIVITY
WO2004106495A3 (en) Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer
SI2400018T1 (en) In tumours differentially expressed gene products and use of the same.
WO2003000012A3 (en) Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast and ovarian cancer
WO2001002568A3 (en) Human genes and gene expression products
WO2004018999A3 (en) Compositions, kits, and methods for identification, assessment, prevention, and therapy of cervical cancer
WO2005039382A3 (en) Prediction of likelihood of cancer recurrence
WO2006009765A3 (en) Methods for the identification and use of compounds suitable for the treatment of drug resistant cancer cells
WO2004080418A3 (en) Nucleic acid compounds for inhibiting angiogenesis and tumor growth
WO2008073878A3 (en) Gene expression profiling of esophageal carcinomas
WO2006037462A3 (en) Cancer markers
WO2005044093A3 (en) Delta-9- the treatment of multiple sclerosis
EP2051077A3 (en) Nucleic acid molecules and proteins for the identification, assessment, prevention, and therapy of ovarian cancer
WO2006018632A3 (en) Cell therapy with exo 1
WO2005000087A3 (en) Gene products differentially expressed in cancerous colon cells and their methods of use ii
AU2003226676A1 (en) Methods and compositions for the identification, assessment, and therapy of small cell lung cancer
WO2004058158A3 (en) Treatment of metastatic cancer with the b-subunit of shiga toxin
WO2005026205A3 (en) Genetic products which are differentially expressed in tumours and use thereof
WO2007076320A8 (en) Compounds
WO2005001039A3 (en) Ribozyme-regulated small inhibitory rna (sirna) production and methods of use thereof
AU2003235791A1 (en) Gene products differentially expressed in cancerous breast cells and their methods of use
WO2005045062A3 (en) Gene expression and polymorphisms associated with lung cancer

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2543965

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2004796566

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2004288177

Country of ref document: AU

ENP Entry into the national phase

Ref document number: 2004288177

Country of ref document: AU

Date of ref document: 20041027

Kind code of ref document: A

WWP Wipo information: published in national office

Ref document number: 2004288177

Country of ref document: AU

WWP Wipo information: published in national office

Ref document number: 2004796566

Country of ref document: EP

WWR Wipo information: refused in national office

Ref document number: 2004796566

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 2004796566

Country of ref document: EP